Doctors contend that current system limits growth opportunities & drive fellow colleagues to private sector. They have set 15 August deadline to implement the policy.
Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.
Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone.
If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be made available free of cost to patients through government hospitals.
In a written reply to a Parliament query, health ministry cited heavy patient load as the reason, adding that critical & emergency surgeries are being prioritised & conducted without delay.
WHO confirmed 9 new cases of polio in the two countries, raising alarm over cross-border transmission due to refugee movements & limited access to vulnerable populations.
Swimming in public pools and water parks comes with risks — from skin irritations to gastrointestinal infections. But it also has a plethora of physical, social and mental health benefits.
After citywide crackdown in June, Delhi govt is moving to curb illegal sale of dual-use and prescription-only drugs. It's an advisory, not mandatory, not all can afford, say pharmacists.
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 crore by 2030, as per estimates.
India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS